Moved by
Lord Patel
40: Clause 4, page 3, line 25, at end insert—
“(f) about requirements to consider babies, children and young people in research about new medicines, in a manner similar to the EU Paediatric Regulation.”
Member’s explanatory statement
This amendment is to ensure that in the development of new medicines and clinical trials, data related to children is taken into consideration.